S&P 500
(-0.60%) 5 235.48 points

Dow Jones
(-0.86%) 38 111 points

Nasdaq
(-1.08%) 16 737 points

Oil
(-0.50%) $77.52

Gas
(-0.74%) $2.55

Gold
(-0.20%) $2 361.70

Silver
(-1.61%) $31.03

Platinum
(-0.75%) $1 030.20

USD/EUR
(0.20%) $0.925

USD/NOK
(0.21%) $10.56

USD/GBP
(0.12%) $0.786

USD/RUB
(0.00%) $90.27

Realtime updates for CureVac N.V. [5CV.DE]

Exchange: XETRA Sector: Healthcare Industry: Biotechnology

Last Updated30 May 2024 @ 11:35

25% discount on Stockinvest.us - Use code: Podcast

-6.16% € 3.38

Live Chart Being Loaded With Signals

Commentary (30 May 2024 @ 11:35):

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA)...

Stats
Today's Volume	132 526
Average Volume	129 216
Market Cap	757.08M
EPS	€0 ( 2024-05-20 )
Next earnings date	( €0 ) 2024-08-15
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-2.77
ATR14	€0.0160 (0.48%)

Volume Correlation

Long: 0.12 (neutral)

Short: 0.37 (neutral)

Signal:(38.343) Neutral

CureVac N.V. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CureVac N.V. Correlation - Currency/Commodity

-0.77
( moderate negative )

-0.70
( moderate negative )

0.00
( neutral )

-0.79
( moderate negative )

-0.45
( neutral )

0.72
( moderate )

CureVac N.V. Financials

Annual	2023
Revenue:	€52.66M
Gross Profit:	€-91.08M (-172.97 %)
EPS:	€-1.150

FY	2023
Revenue:	€52.66M
Gross Profit:	€-91.08M (-172.97 %)
EPS:	€-1.150

FY	2022
Revenue:	€67.42M
Gross Profit:	€-116.57M (-172.91 %)
EPS:	€-1.320

FY	2021
Revenue:	€102.99M
Gross Profit:	€-135.21M (-131.28 %)
EPS:	€-2.34

Financial Reports:

No articles found.

CureVac N.V. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

CureVac N.V.

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.